Premium
Open‐label pilot study of tofacitinib 2% for the treatment of refractory vitiligo
Author(s) -
Mobasher P.,
Guerra R.,
Li S.J.,
Frangos J.,
Ganesan A.K.,
Huang V.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.18606
Subject(s) - medicine , vitiligo , dermatology , family medicine